RNS Number : 0526F
BioPharma Credit PLC
15 February 2018
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

 

 

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:

BioPharma Credit Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

No

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

No

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

No

An event changing the breakdown of voting rights

No

Other (please specify):

Placing of Shares

Yes

3. Full name of person(s) subject to the
notification obligation:

Invesco Limited

4. Full name of shareholder(s)
 (if different from 3.):

 

5. Date of the transaction and date on
which the threshold is crossed or
reached:

30 March 2017

6. Date on which issuer notified:

31 March 2017

7. Threshold(s) that is/are crossed or
reached:

5%,10%,11%,12%,13%,14%,15%,16%,17%,18%,19%
           
 

 

8. Notified details:

A: Voting rights attached to shares

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights

Direct

Direct

Indirect

Direct

Indirect

Ordinary Shares

N/A

N/A

 

 

150,000,000

 

19.69%

GB00BDGKMY29

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date

Exercise/
Conversion Period

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

 

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date

Exercise/
Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 

 

 

 

 

 

 

Nominal

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

150,000,0000

19.69%
                                 
 

 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:

Invesco Asset Management Limited - 150,000,000

 

 

Proxy Voting:

10. Name of the proxy holder:

Invesco Limited

11. Number of voting rights proxy holder will cease
to hold:

N/A

12. Date on which proxy holder will cease to hold
voting rights:

N/A

 


13. Additional information:


 

14. Contact name:

Philippa Holmes

15. Contact telephone number:

01491 417 447

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUVRNRWUAUAAR